JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells. (2021)
Attributed to:
Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2020002702
PubMed Identifier: 33560400
Publication URI: http://europepmc.org/abstract/MED/33560400
Type: Journal Article/Review
Volume: 5
Parent Publication: Blood advances
Issue: 3
ISSN: 2473-9529